Aspocomp Group Oyj (ACG1V)
Nasdaq Helsinki · Finland · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 6.220 |
|---|---|
| 52-week range | 4.300 – 6.760 |
| Return, 1 month / 3 months | +8.4% / +17.4% |
| Return, 1 year / 3 years | +19.6% / +74.7% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 39.3% |
| Worst drawdown (1 year) | -21.4% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aspocomp Group Oyj is a Finnish manufacturer of printed circuit boards. The company produces circuit boards and related technology services for customers in the electronics industry, serving applications that require reliable interconnection of electronic components. Its customers include companies that design and manufacture electronic devices and systems. Aspocomp is based in Finland, where it carries out its circuit board production and serves its customer base.
The shares are listed on the Nasdaq Helsinki in Finland under the code ACG1V, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aspocomp Group Oyj (ACG1V) trades on the Nasdaq Helsinki in Finland. It last closed at EUR 6.220 on 27 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 54 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.6% and over the last three months it rose 17.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Helsinki
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.5% | ||
| From 52-week high | -4.0% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 17.4% | ||
| 6-month return | 27.2% | ||
| 12-month return, skipping the last month | 10.4% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 39.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.4% | ||
| Liquidity | 29 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | +8.4% |
| 3 months | +17.4% |
| 6 months | +27.2% |
| 1 year | +19.6% |
| 3 years | +74.7% |
| 5 years | +31.8% |
Signals
| 50-day / 200-day average | 5.646 / 5.206 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.216 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Apr 2023 | EUR 0.2100 |
| 27 Apr 2022 | EUR 0.1500 |
| 17 Sep 2020 | EUR 0.1500 |
| 4 Apr 2019 | EUR 0.1200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Helsinki; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.